Skip to content
Profiles

Alesta Therapeutics

Alesta Therapeutics is a Netherlands and Boston-based biotechnology company developing novel oral small molecule therapies for underserved rare diseases.

Their work is focused on addressing a genetic subtype of Charcot-Marie-Tooth disease. To achieve this, they are combining their in-house expertise with the knowledge of global academic and industry-leading experts, such as CMTA. They are proud to collaborate with Professor Dr. Rob Burgess from the Jackson Laboratories, a renowned figure in this field.